FMO5 and chronic granulomatous disease: The importance of ROS in host protection is highlighted in the setting of Chronic Granulomatous Disease (CGD), a disease characterized by genetic mutations in the NADPH oxidase, where patients are unable to make ROS and are susceptible to Klebsiella infections (Wolach et al., 2017; Bortoletto et al., 2015).